Literature DB >> 15366434

Doxycycline ameliorates ischemic and border-zone remodeling and endothelial dysfunction after myocardial infarction in rats.

Teresa M Camp1, Sam C Tyagi, Giorgio M Aru, Melvin R Hayden, Jay L Mehta, Suresh C Tyagi.   

Abstract

BACKGROUND: Although matrix metalloproteinase (MMP) activity increases, endothelial function decreases after myocardial infarction (MI). The antibiotic doxycycline inhibits MMP activity in vitro. The role of doxycycline-mediated MMP inhibition in endothelial function is unclear. HYPOTHESIS: Doxycycline ameliorates endothelial dysfunction, in part, by inhibiting MMP activity.
METHODS: We subjected Sprague-Dawley male rats to MI by ligating the left anterior descending arteries. We subjected another group of rats to sham surgery. We administered doxycycline in drinking water (0.67 mg/ml) to both groups 2 days before surgery: the sham group underwent sham surgery and received doxycycline therapy, and the MI group underwent MI and received doxycycline therapy (n = 6 in each group). After 4 weeks, we anesthetized rats and prepared left ventricular rings from infarcted-ischemic (I), non-infarcted near-infarcted (NI), and sham surgery hearts with and without doxycycline treatment.
RESULTS: The MMP-2 activity increased significantly in I and NI hearts, and we observed a selective increase in MMP-9 activity only in I hearts, when compared with other groups (p < 0.05), measured by zymography. Cardiac inhibitor of metalloproteinase decreased only in I hearts (p < 0.05 vs other groups), measured by Western analysis, and doxycycline treatment reversed this decrease. Contractile response of rings to acetylcholine was attenuated in the I group, suggesting nitric oxide-mediated dysfunction, and was reversed by doxycycline. The response to nitroprusside was attenuated in I hearts and ameliorated by doxycycline, suggesting cardiomyocyte dysfunction. Bradykinin induced relaxation in rings from sham surgery hearts and from NI hearts, but induced paradoxic contraction in rings from I hearts. Treatment with doxycycline reversed the paradoxic contraction.
CONCLUSION: Results suggest a protective action of doxycycline in the ischemic heart, possibly because of additional pharmacologic actions such as metalloproteinase inhibition.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15366434     DOI: 10.1016/j.healun.2003.06.005

Source DB:  PubMed          Journal:  J Heart Lung Transplant        ISSN: 1053-2498            Impact factor:   10.247


  14 in total

Review 1.  Mechanisms of I/R-Induced Endothelium-Dependent Vasodilator Dysfunction.

Authors:  Ronald J Korthuis
Journal:  Adv Pharmacol       Date:  2017-12-08

2.  miR-29b as a therapeutic agent for angiotensin II-induced cardiac fibrosis by targeting TGF-β/Smad3 signaling.

Authors:  Yang Zhang; Xiao-Ru Huang; Li-Hua Wei; Arthur Ck Chung; Cheuk-Man Yu; Hui-Yao Lan
Journal:  Mol Ther       Date:  2014-02-26       Impact factor: 11.454

3.  Dysbiosis and Disease: Many Unknown Ends, Is It Time to Formulate Guidelines for Dysbiosis Research?

Authors:  Sudhakar Veeranki; Suresh C Tyagi
Journal:  J Cell Physiol       Date:  2017-04-12       Impact factor: 6.384

4.  Dysbiotic 1-carbon metabolism in cardiac muscle remodeling.

Authors:  Akash K George; Mahavir Singh; S Pushpakumar; Rubens P Homme; Shanna J Hardin; Suresh C Tyagi
Journal:  J Cell Physiol       Date:  2019-09-05       Impact factor: 6.384

Review 5.  Nitrosative stress and pharmacological modulation of heart failure.

Authors:  Pal Pacher; Richard Schulz; Lucas Liaudet; Csaba Szabó
Journal:  Trends Pharmacol Sci       Date:  2005-06       Impact factor: 14.819

Review 6.  Epigenetic memory: gene writer, eraser and homocysteine.

Authors:  Suresh C Tyagi; Dragana Stanisic; Mahavir Singh
Journal:  Mol Cell Biochem       Date:  2020-10-08       Impact factor: 3.396

Review 7.  Matrix Metalloproteinases in Myocardial Infarction and Heart Failure.

Authors:  Kristine Y DeLeon-Pennell; Cesar A Meschiari; Mira Jung; Merry L Lindsey
Journal:  Prog Mol Biol Transl Sci       Date:  2017-03-18       Impact factor: 3.622

Review 8.  Matrix metalloproteinases and myocardial infarction.

Authors:  Wannakorn Phatharajaree; Arintaya Phrommintikul; Nipon Chattipakorn
Journal:  Can J Cardiol       Date:  2007-07       Impact factor: 5.223

9.  Molecular Signals Elicited by GPCR Agonists in Hypertension, Cardiovascular Remodeling: Are MMPs and ADAMs Elusive Therapeutic Targets?

Authors:  Xiang Wang; Ana-Maria Bosonea; Jeffrey Odenbach; Carlos Fernandez-Patron
Journal:  Curr Hypertens Rev       Date:  2012-08-01

Review 10.  Myofibroblasts and the extracellular matrix network in post-myocardial infarction cardiac remodeling.

Authors:  Yonggang Ma; Lisandra E de Castro Brás; Hiroe Toba; Rugmani Padmanabhan Iyer; Michael E Hall; Michael D Winniford; Richard A Lange; Suresh C Tyagi; Merry L Lindsey
Journal:  Pflugers Arch       Date:  2014-02-13       Impact factor: 3.657

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.